Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Understanding codeine sits at the center of this dementia and brain health question.
Codeine cough syrup should generally not be used for nasal congestion, and modern medical evidence suggests it’s not effective for cough suppression in the first place. The FDA has progressively restricted codeine use over the past decade, first banning it in children under 12 in 2017, then extending that ban to everyone under 18 in 2018.
For someone managing a respiratory infection alongside congestion—a common situation in older adults or those with chronic health conditions—there are safer, more effective alternatives that don’t carry the risks of respiratory depression or dependency that codeine presents. The real problem is that many people still have old bottles of codeine cough syrup in their medicine cabinets, or they encounter prescriptions from providers who haven’t updated their practice. This article is designed to help you understand why these medications have fallen out of favor, what the current medical consensus says about their effectiveness, and what your options actually are when you’re dealing with both a cough and nasal congestion.
Table of Contents
- Why Did the FDA Restrict Codeine, and What Does That Mean for You?
- The Uncomfortable Truth: Codeine Doesn’t Actually Work
- Codeine and Nasal Congestion: Why They’re Often Paired (and Why It’s Misleading)
- What Actually Works for Congestion: Current Medical Recommendations
- The Risk of Respiratory Depression: A Particular Concern for Older Adults
- Constipation and Cognitive Side Effects: The Overlooked Consequences
- What to Do If You Have an Old Prescription or Bottle
- Conclusion
Why Did the FDA Restrict Codeine, and What Does That Mean for You?
The FDA’s restrictions on codeine weren’t made lightly. Between April 2017 and January 2018, the agency issued two major safety actions: first prohibiting codeine use in children aged 0 to 11 years, then expanding the restriction to anyone under 18. These actions followed documented cases of life-threatening respiratory depression and death in children who received codeine, particularly those with undiagnosed breathing problems. The agency recognized that children’s bodies metabolize codeine differently—some people have genetic variations that cause them to convert codeine to morphine much faster than others, creating dangerous concentrations of the drug in their system.
While these initial restrictions focused on children, they were a signal that codeine itself posed problems even when used as directed. The evidence supporting this restriction applies to adults as well, though the absolute risk is lower in adults without underlying breathing problems. If you’re a caregiver for someone with dementia, respiratory issues, sleep apnea, or obesity—conditions that are relatively common in older adults—the risk of respiratory depression becomes significantly more concerning. For older adults specifically, codeine carries additional risks. Cognitive side effects, constipation, and drug interactions are more likely in people over 65, and codeine’s sedating properties can increase fall risk, a major concern for anyone managing dementia-related balance or judgment issues.
The Uncomfortable Truth: Codeine Doesn’t Actually Work
Here’s the part that contradicts decades of marketing and habit: research shows that codeine is no more effective than placebo at suppressing cough caused by upper respiratory infections or chronic lung disease. When you take a placebo—a fake pill—and a codeine cough syrup side by side in a clinical study, patients report the same level of cough relief. This finding comes from rigorous placebo-controlled trials, the gold standard of medical research, and it explains why prescriptions for codeine cough products have collapsed: from 232,140 prescriptions in 2014 to just 23,008 in 2019, a 90.1% decline. The decline reflects doctors and patients catching up to the science.
If a medication doesn’t work better than a sugar pill, then all you’re getting from codeine is the side effects—the constipation, the cognitive fog, the respiratory depression risk—without the benefit. For someone with dementia or cognitive impairment, even mild sedation or confusion can have outsize consequences on daily functioning and safety. The nasal congestion angle adds another layer of ineffectiveness. Codeine doesn’t directly address congestion; it’s often combined with other ingredients like phenylephrine or decongestants in combination products. But if codeine itself provides no added benefit over placebo, and the decongestant component carries its own concerns (which we’ll discuss), the product becomes a problematic choice.
Codeine and Nasal Congestion: Why They’re Often Paired (and Why It’s Misleading)
Manufacturers combined codeine with decongestants or antihistamines because they wanted to create a single product that addressed multiple cold or allergy symptoms. A person with a sinus infection might experience both a cough and nasal stuffiness, so the thinking went: why not combine drugs that address each problem? This marketing strategy worked well for decades, but it conflated symptom-relief with actual effectiveness. When you look at what’s actually in these combination products, you typically find codeine paired with phenylephrine (a decongestant) or promethazine (an antihistamine). The decongestant might provide some short-term congestion relief, and the antihistamine can help with post-nasal drip—but the codeine is along for the ride based on tradition rather than science.
Because codeine doesn’t work, you’re essentially paying for the less effective components of the product while accepting all the risks that codeine carries. This is particularly important for older adults or anyone with cognitive concerns. If you’re taking a combination product “for the congestion,” you don’t want codeine complicating the picture with sedation or confusion. The modern approach is to separate these treatments and choose products specifically designed for the symptom you’re actually trying to treat.
What Actually Works for Congestion: Current Medical Recommendations
Today’s evidence-based approach for nasal congestion combines two types of medications: a daily second-generation antihistamine (like cetirizine, loratadine, or fexofenadine) plus a daily intranasal corticosteroid spray (like fluticasone or mometasone). This combination addresses both the histamine reaction that causes swelling and the inflammation that makes congestion feel unbearable. Unlike older antihistamines, second-generation versions don’t cause the same level of drowsiness, making them safer for older adults or anyone with cognitive concerns. The intranasal corticosteroid is the workhorse here.
When used consistently over several days, it genuinely reduces inflammation in the nasal passages and is far more effective than decongestants alone. This is the recommendation from major medical centers like Mayo Clinic and is backed by current systematic reviews of the evidence. The advantage over older treatments is that you’re not chasing symptom relief with pills every few hours; instead, you’re addressing the root cause of congestion by reducing inflammation. If someone needs additional relief beyond this foundation, newer decongestants like oxymetazoline (Afrin) or xylometazoline (Otrivin) can be used short-term without worry about the rebound congestion that was previously feared. Recent systematic reviews from 2025 and 2026 found no evidence of rebound congestion after 7 days with oxymetazoline or up to 10 days with xylometazoline, so brief use is safe for most people.
The Risk of Respiratory Depression: A Particular Concern for Older Adults
Respiratory depression—essentially, the slowing of breathing to dangerous levels—is the most serious side effect of codeine, and it’s the reason the FDA took action. In children, this happened relatively frequently and sometimes fatally. In adults, the risk is lower but still present, especially in specific groups. Anyone with sleep apnea, obesity, chronic obstructive pulmonary disease (COPD), asthma, or other breathing-related conditions faces elevated risk. For someone with dementia, there’s an additional layer of concern.
If a person’s breathing becomes shallow, they may not communicate distress effectively, and they may not notice changes in their own symptoms. A caregiver would need to monitor closely, watching for signs like unusually slow breathing, extreme drowsiness, or difficulty waking. This kind of vigilance is sometimes impossible in real-world caregiving, especially in facilities or settings where one caregiver is managing multiple residents. The combination of codeine with other sedating drugs—which is common in older adults taking multiple medications—increases the risk exponentially. If someone is on a benzodiazepine for anxiety, an opioid for pain, or a sedating antihistamine, adding codeine is genuinely dangerous and should be avoided entirely.
Constipation and Cognitive Side Effects: The Overlooked Consequences
Beyond respiratory depression, codeine causes constipation in a significant percentage of users—sometimes up to 30% or more, depending on the dose. For older adults and people with dementia, constipation is a serious problem. It can lead to bowel obstruction, delirium, or severe discomfort.
If someone is already on pain medications or other drugs that slow the gut, codeine becomes a particularly bad choice. The cognitive effects—drowsiness, confusion, difficulty concentrating—are also important in the dementia context. A person with mild cognitive impairment who takes codeine might experience noticeable worsening of their thinking or memory for the duration of the medication. Family members might interpret this as decline in the underlying condition rather than a medication effect, leading to unnecessary concern or inappropriate interventions.
What to Do If You Have an Old Prescription or Bottle
If you or a family member have an old bottle of codeine cough syrup, the safest approach is not to use it. If you have a current prescription for a codeine cough product, talk to your doctor or pharmacist about switching to a more modern regimen. Modern alternatives are available, often over the counter, and they’re supported by current evidence in a way that codeine simply isn’t.
For future respiratory infections or allergy-related congestion, consider starting with a daily antihistamine and intranasal corticosteroid spray. These address the actual underlying problems—inflammation and histamine response—without the risks. If you need additional support, your provider can recommend decongestants or other options based on your specific situation, but you’ll be starting from a foundation of proven, safe treatments rather than relying on a medication that doesn’t work and carries real risks.
Conclusion
Codeine cough syrup represents an outdated approach to managing coughs and congestion. The FDA restricted its use in children based on documented harms, medical evidence shows it’s no more effective than placebo at suppressing cough, and modern alternatives are safer and more effective. For anyone managing dementia, cognitive concerns, or multiple medications, the risks of codeine are particularly significant: respiratory depression, constipation, confusion, and potentially dangerous drug interactions.
If you’re dealing with nasal congestion and cough, ask your doctor about evidence-based alternatives: a daily second-generation antihistamine combined with an intranasal corticosteroid spray. These address the root causes of congestion rather than just masking symptoms, they work reliably, and they carry a much lower risk profile—especially for older adults and anyone with underlying health conditions. The medical consensus has moved forward; your medicine cabinet should too.
You Might Also Like
- Alka-Seltzer Plus and Reduced Taste: A Plain-English Guide
- Allegra and Body Aches From a Cold: A Plain-English Guide
- Should You Try Oscillococcinum for Nasal Congestion?
For more, see Alzheimer’s Association.
